JeffreySFreemanDO

PubMed

• 24 citations
  Management of Hypoglycemia in Older Adults with Type 2 Diabetes
  Jeffrey S. Freeman> ;Postgraduate Medicine. 2019 Feb 26
• 1 citations
  Hot Topics in Primary Care: Considerations in the Selection of Antihyperglycemic Therapy for Older Patients With Type 2 Diabetes Mellitus: A Focus on Newer Therapies.
  Jeffrey S. Freeman> ;Journal of Family Practice. 2015 Dec 1
• 1 citations
  Initial Combination Therapy for Patients with Type 2 Diabetes Mellitus: Considerations for Metformin Plus Linagliptin
  Jeffrey S. Freeman> ;Drugs in context. 2013 Aug 21
• 17 citations
  Review of Insulin-Dependent and Insulin-Independent Agents for Treating Patients With Type 2 Diabetes Mellitus and Potential Role for Sodium-Glucose Co-Transporter 2 I...
  Jeffrey S. Freeman> ;Postgraduate Medicine. 2013 May 1
• 2 citations
  What have we learned about the treatment of type 2 diabetes? The evolving paradigms.
  Jeffrey S. Freeman, Edward S. Horton> ;American Journal of Therapeutics. 2012 Nov 1
• 4 citations
  Improving Glucagon-like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2012 Jan 1
• 3 citations
  Common patient concerns about the use of glucagon-like peptide-1 receptor agonists in diabetes mellitus management.
  Jeffrey S. Freeman, James R. Gavin, Craig W. Spellman> ;The Journal of the American Osteopathic Association. 2012 Jan 1
• 13 citations
  Potential drug interactions associated with treatments for type 2 diabetes and its comorbidities: a clinical pharmacology review.
  Jeffrey S. Freeman, Benjamin N Gross> ;Expert Review of Clinical Pharmacology. 2012 Jan 1
• 10 citations
  Type 2 diabetes mellitus: practical approaches for primary care physicians.
  James R. Gavin, Jeffrey S. Freeman, Jay H. Shubrook, Frank Lavernia> ;The Journal of the American Osteopathic Association. 2011 May 1
• 9 citations
  Optimizing outcomes for GLP-1 agonists.
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2011 Feb 1
• 14 citations
  A Physiologic and Pharmacological Basis for Implementation of Incretin Hormones in the Treatment of Type 2 Diabetes Mellitus
  Jeffrey S. Freeman> ;Mayo Clinic proceedings. 2010 Dec 1
• 7 citations
  Managing Hyperglycemia in Patients With Type 2 Diabetes Mellitus: Rationale for the Use of Dipeptidyl Peptidase-4 Inhibitors in Combination With Other Oral Antidiabeti...
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2010 Sep 1
• 8 citations
  The increasing epidemiology of diabetes and review of current treatment algorithms.
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2010 Jul 1
• Illustrative case and discussion: a 58-year-old man with diabetes.
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2010 Jul 1
• 10 citations
  Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.
  James R. Gavin, Mark W. Stolar, Jeffrey S. Freeman, Craig W. Spellman> ;The Journal of the American Osteopathic Association. 2010 May 1
• 2 citations
  Are Analogue Insulins Superior to Human Insulin in Clinical Practice
  Jeffrey S. Freeman> ;Current Diabetes Reports. 2010 Mar 26
• 4 citations
  New Therapeutic Options: Management Strategies to Optimize Glycemic Control
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2010 Mar 1
• 38 citations
  Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
  Jeffrey S. Freeman> ;Cleveland Clinic Journal of Medicine. 2009 Dec 1
• 26 citations
  Insulin analog therapy: improving the match with physiologic insulin secretion.
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2009 Jan 1
• 2 citations
  Why and when to implement incretin therapy.
  Jeffrey S. Freeman, Jeff Unger> ;Journal of Family Practice. 2008 Sep 1
• 1 citations
  Treating Hispanic Patients for Type 2 Diabetes Mellitus: Special Considerations
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2008 May 1
• 11 citations
  The pathophysiologic role of incretins.
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2007 May 1
• 5 citations
  Application of Incretin Mimetics and Dipeptidyl Peptidase IV Inhibitors in Managing Type 2 Diabetes Mellitus
  Patrick J. Boyle, Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2007 May 1
• Reducing the "domino effect" of the metabolic syndrome.
  Jeffrey S. Freeman> ;The Journal of the American Osteopathic Association. 2007 Apr 1
• Blood glucose in the hospital. Doctors are starting to see that tight glucose control saves lives.
  Jeffrey S. Freeman> ;Diabetes forecast. 2005 Sep 1
• Join now to see all